Agilent Technologies and Strand Scientific Intelligence have announced that they will be teaming up to expand the scope of the Agilent GeneSpring bioinformatics system across multiple life-science disciplines, drive future innovation and deliver new channels for accessing the software and customer support.
Agilent Technologies and Strand Scientific Intelligence have announced that they will be teaming up to expand the scope of the Agilent GeneSpring bioinformatics system across multiple life-science disciplines, drive future innovation and deliver new channels for accessing the software and customer support.
"Developing new scientific intelligence solutions that enable scientists to integrate, model and visualize biological information is an important part of this new agreement, and we also look forward to going beyond this, developing new ways to deliver, customize and support these solutions." said Francois Mandeville, Strand executive vice president.
"We intend to lead the way in providing tools for integrated biology research, and partnering with Strand is an excellent way of addressing the all-important bioinformatics part of the equation," said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. "Studies combining multiple 'omics experiments are finally delivering the results that were hoped for years ago from systems biology and true translational research, and this is one example of what Agilent is doing to fuel future breakthroughs in biomedical research."
The first tool scheduled to emerge from this partnership will be a version of GeneSpring designed to help users perform statistical analyses of and visualize data from genomics, metabolomics and proteomics together for the first time, using a familiar interface. The partnership also will leverage Strand's technology to enable integrated Next Generation Sequencing analysis capabilities for GeneSpring users.
For more information visit www.strandsi.com and www.agilent.com
Extraction of 40 PFAS Compounds from Soil and Tissue
December 6th 2024PFAS have been shown to cause health issues in humans, which means monitoring environmental solid samples, such as soil and tissue, is critical. This application note details the extraction of 40 spiked PFAS compounds from soil and tissue following EPA Method 1633. The automated extraction was less than 10 minutes per sample and yielded acceptable recoveries and RSDs without carryover in the system. The EDGE PFAS is an ideal option for laboratories that want to automate their PFAS extractions of solid samples.